Cassava Sciences, Inc. (SAVA)
收市後：
| 前收市價 | 16.64 |
| 開市 | 16.70 |
| 買盤 | 16.81 x 900 |
| 賣出價 | 16.72 x 1300 |
| 今日波幅 | 16.41 - 17.02 |
| 52 週波幅 | 16.41 - 46.29 |
| 成交量 | |
| 平均成交量 | 947,261 |
| 市值 | 705.096M |
| Beta 值 (5 年，每月) | -0.09 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.18 |
| 業績公佈日 | 2023年11月06日 - 2023年11月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 2012年12月13日 |
| 1 年預測目標價 | 99.50 |
InvestorPlaceThe 7 Best Meme Stocks to Buy Now: September 2023
Given the horrendous performance of meme kings like AMC Entertainment (NYSE:AMC) and GameStop (NYSE:GME) lately, searching for the best meme stocks may be the last thing on your mind right now. In fact, considering GME’s continued declines, and AMC’s capitulation in recent weeks, you may think that the meme stock phenomenon has completely gone the way of the dodo. However, even as the stocks that sparked this investing phenomenon in early 2021 has retreated to more rational prices, a crop of new
InvestorPlaceWhy These 3 Stocks Are the Worst Ways to Play Biotech Right Now
The tech and growth segments of the market have been having a tremendous 2023 with one glaring exception. Traders have been choosing to avoid biotech stocks amid macroeconomic uncertainty around the sector. With the upturn in market sentiment and improving access to funding, however, biotech stocks should be primed for better performance going forward. It’s vital to pick carefully, however. Some high-risk biotech stocks are unlikely to make investors money over the long term regardless of what h
InvestorPlace3 Biotech Stocks to Avoid Like the Plague
Biotech stocks have gotten caught up in the broader technology sector sell-off. The benchmark iShares Biotechnology ETF (NYSEARCA:IBB) has fallen from a peak of $175 in 2021 to just $130 today. There are few signs of a biotech stock bubble at this point. That said, even with the sector at an overall discount, that’s not an all-clear for the whole sector. Many of the worst biotech stocks either have a drug prospect that is unlikely to get FDA approval or one that simply never garners much commerc
